HS135

N/A

Report date: 2025/09/05 20:01:20

Base Information

Drug NameHS135
Drug Alias NameHS-135
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGrowth/differentiation factor 8 inhibitorsActivin receptor type-1 inhibitors
TargetsGrowth/differentiation factor 8Activin receptor type-1
Therapy Area/IndicationsHeart Failure, DiastolicPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator Companies35Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies35Pharma Inc
Active IndicationsN/A
Inactive IndicationsHeart Failure, DiastolicPulmonary Arterial HypertensionHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A